Drug Profile
Silver dihydrogen citrate
Alternative Names: Axenohl; SDCLatest Information Update: 05 Nov 2021
Price :
$50
*
At a glance
- Originator PURE Bioscience
- Developer FTA Bioscience; PURE Bioscience
- Class
- Mechanism of Action DNA inhibitors; Membrane protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Acne vulgaris; Bacterial vaginosis; Onychomycosis; Tinea pedis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Acne-vulgaris in USA (Topical)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-vaginosis in USA
- 04 Nov 2017 No recent reports of development identified for preclinical development in Onychomycosis in USA (Topical)